Several companies including PubMatic Inc, TransMedics, PAR Technology Corporation, SI-BONE, Inc, Cytokinetics, Kiniksa Pharmaceuticals, Novavax, Mirum Pharma, Marathon Digital Holdings, Verano, and Trulieve have reported their fourth quarter and fiscal year 2023 financial results. Novavax missed quarterly estimates but narrowed losses, with revenue of $291 million in Q4 and $1 billion for FY'23, providing guidance of $800 million to $1 billion for FY'24.
Verano Announces Fourth Quarter and Full Year 2023 Financial Results $VRNO $VRNOF https://t.co/wOixWnLG49
Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End Momentum and Cash Generation $TRUL $TCNNF https://t.co/PDGbqwnQfv
Marathon Digital Holdings Reports Fourth Quarter and Fiscal Year 2023 Results :: Marathon Digital Holdings (MARA) https://t.co/fng9XCbt9E
$MIRM 🇺🇸 Mirum Pharma Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update https://t.co/hbfKUX3gI2 https://t.co/O07YXiJPkN
After steep cost cuts, Novavax's fourth-quarter performance falls short of expectations https://t.co/5ngQi6x4EI
Vas right now. $CYTK https://t.co/6oP5YGmH8w
Novavax says still faces strong headwinds, 2024 sales flat to lower https://t.co/aNqQYgdqi1 https://t.co/u3jTxEikjE
Novavax Stock Sinks as Revenue Misses Estimates in ‘Transition Year’ https://t.co/5OHf7mY5YO
Novavax misses quarterly estimates, but vaccine maker narrows losses as it slashes costs https://t.co/DYnpjfF95w
$NVAX Q4 revenues $291M and FY'23 revenue of $1 billion. FY'24 total revenue guidance of $800 million to $1 billion
$KNSA 🇺🇸 Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution https://t.co/zdgJMH41aS https://t.co/xfXPQ5vJ1I
$NVAX well it finally did it https://t.co/iwNTtEqRHe https://t.co/ubK5nghsF2
$CYTK 🇺🇸 Cytokinetics Reports Fourth Quarter 2023 Financial Results https://t.co/fe7Q8icN6g Webcast https://t.co/9oavzIBC4k https://t.co/iPJeNopi5R
$SIBN (-7.5% pre) SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance https://t.co/WFv9dSz00g
$PAR (-1.1% pre) PAR Technology Corporation Announces Fourth Quarter and Full Year 2023 Results https://t.co/n20iLBWECk
$TMDX (+17.1% pre) TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results https://t.co/1USxBL6mkm
$PUBM (+28.2% pre) PubMatic Inc (PUBM) Reports Robust Q4 and Fiscal Year 2023 Results; Expands Share Repurchase Program https://t.co/8YCeXQLlAo